Emergent BioSolutions EBS
NYSE EBS
$6.14 -0.22 (-3.53%)
As of: Oct 20, 2026 · 11:34 AM EDT

Emergent BioSolutions (EBS) FCF Margin (2011 - 2026)

Updated

Emergent BioSolutions (EBS) posted FCF Margin of 23.05% for Q2 2026, down 50.41 percentage points from 73.46% a year earlier but up 46.24 percentage points from the prior quarter.

Analysis

Emergent BioSolutions (EBS) FCF Margin (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, FCF Margin at Emergent BioSolutions was 11.15%, down 7.05 percentage points year-over-year; for FY2025, it came in at 21.11%, up 17.68 percentage points from FY2024.

  • Annual FCF Margin has increased for three consecutive years, though with a five-year change of -3.94 percentage points (FY2020 to FY2025).
  • In prior years, Emergent BioSolutions' FCF Margin was 3.43% in FY2024 (+28.01 pp), -24.58% in FY2023 (+0.28 pp), -24.86% in FY2022 (-30.28 pp) and 5.42% in FY2021 (-19.62 pp).
  • Quarterly FCF Margin has run from a low of -121.18% in Q1 2023 to a high of 73.46% in Q2 2025 over five years.
  • On a year-over-year basis, FCF Margin increased in four of the last eight quarters, with an average year-over-year change of +3.70 percentage points.
  • The strongest year-over-year quarter for FCF Margin in the past five years was Q3 2023, with a gain of 123.15 percentage points; the weakest was Q1 2023, with a drop of 98.38 percentage points.
  • According to Business Quant data, FCF Margin for the three prior quarters was -23.19% (Q1 2026), 49.63% (Q4 2025) and -2.47% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,157.21 Bn 1,125.80 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 624.79 Bn 543.32 Bn 17.26 Bn 28.82%
3 AbbVie 511.04 Bn 484.15 Bn 12.70 Bn 18.33%
4 Merck 365.98 Bn 320.36 Bn 12.21 Bn 26.96%
5 Novartis Ag 296.82 Bn 260.81 Bn 11.24 Bn 38.60%
6 Astrazeneca 260.38 Bn 234.06 Bn 12.86 Bn 6.55%
7 Amgen 234.75 Bn 190.15 Bn 7.24 Bn 34.70%
8 Gilead Sciences 193.87 Bn 168.07 Bn 6.22 Bn 44.00%
9 Pfizer 171.45 Bn 118.10 Bn 10.94 Bn 2.01%
10 Emergent BioSolutions 317.34 Mn -433.56 Mn 137.20 Mn 23.05%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.05%
Mar 31, 2026 -23.19%
Dec 31, 2025 49.63%
Sep 30, 2025 -2.47%
Jun 30, 2025 73.46%
Mar 31, 2025 -6.66%
Dec 31, 2024 -41.91%
Sep 30, 2024 50.34%
Jun 30, 2024 16.84%
Mar 31, 2024 -24.43%
Dec 31, 2023 7.48%
Sep 30, 2023 17.52%
Jun 30, 2023 -37.56%
Mar 31, 2023 -121.18%
Dec 31, 2022 20.96%
Sep 30, 2022 -144.06%
Jun 30, 2022 -19.66%
Mar 31, 2022 -22.80%
Dec 31, 2021 38.52%
Sep 30, 2021 -13.45%
API Access

Emergent BioSolutions FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY